Cerevia Neurosciences is developing a closed-loop, fMRI-guided neuromodulation platform for dementia care, centered on its compact Ladybug™ Sanctuary unit. The company combines AI-driven personalization with integrated brain imaging to deliver non-invasive therapy in clinical and memory-care settings. Cerevia is a spin-out of the Weinberg Medical Holdings venture studio and holds more than 35 U.S. and international patents.